BioCentury
ARTICLE | Company News

HemaSure, In-Line Diagnostics, American Red Cross deal

April 15, 2013 7:00 AM UTC

The companies signed a letter of intent with the Red Cross to develop a non-invasive anemia screening device based on In-Line's hematocrit technology. The electronic device would screen blood donors f...